The study suggested that SULT2B1 (rs10426628) lowers the risk of prostate cancer progression by reducing the circulating steroid hormones via forming less active sulfated metabolites (Levesque et al., 2014). This evidence concerns the gene SULT2B1 and prostate cancer.